220 related articles for article (PubMed ID: 32623652)
21. Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry.
Walker UA; Tilson HH; Hawkins PN; Poll TV; Noviello S; Levy J; Vritzali E; Hoffman HM; Kuemmerle-Deschner JB;
RMD Open; 2021 May; 7(2):. PubMed ID: 34001647
[TBL] [Abstract][Full Text] [Related]
22. Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome.
Kuemmerle-Deschner JB; Hofer F; Endres T; Kortus-Goetze B; Blank N; Weißbarth-Riedel E; Schuetz C; Kallinich T; Krause K; Rietschel C; Horneff G; Benseler SM
Rheumatology (Oxford); 2016 Apr; 55(4):689-96. PubMed ID: 26667214
[TBL] [Abstract][Full Text] [Related]
23. Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes.
Church LD; McDermott MF
Expert Rev Clin Immunol; 2010 Nov; 6(6):831-41. PubMed ID: 20979548
[TBL] [Abstract][Full Text] [Related]
24. Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study.
Koné-Paut I; Lachmann HJ; Kuemmerle-Deschner JB; Hachulla E; Leslie KS; Mouy R; Ferreira A; Lheritier K; Patel N; Preiss R; Hawkins PN;
Arthritis Res Ther; 2011; 13(6):R202. PubMed ID: 22152723
[TBL] [Abstract][Full Text] [Related]
25. Necrotizing Funisitis as an Intrauterine manifestation of Cryopyrin-Associated Periodic Syndrome: a case report and review of the literature.
Yokoi K; Minamiguchi S; Honda Y; Kobayashi M; Kobayashi S; Nishikomori R
Pediatr Rheumatol Online J; 2021 May; 19(1):77. PubMed ID: 34059097
[TBL] [Abstract][Full Text] [Related]
26. Guidance on the use of canakinumab in patients with cryopyrin-associated periodic syndrome in Japan.
Yokota S; Nishikomori R; Takada H; Kikuchi M; Nozawa T; Kanetaka T; Kizawa T; Miyamae T; Mori M; Heike T; Hara T; Imagawa T
Mod Rheumatol; 2013 May; 23(3):425-9. PubMed ID: 23085882
[TBL] [Abstract][Full Text] [Related]
27.
Nakanishi H; Kawashima Y; Kurima K; Chae JJ; Ross AM; Pinto-Patarroyo G; Patel SK; Muskett JA; Ratay JS; Chattaraj P; Park YH; Grevich S; Brewer CC; Hoa M; Kim HJ; Butman JA; Broderick L; Hoffman HM; Aksentijevich I; Kastner DL; Goldbach-Mansky R; Griffith AJ
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7766-E7775. PubMed ID: 28847925
[TBL] [Abstract][Full Text] [Related]
28. A novel knock-in mouse model of cryopyrin-associated periodic syndromes with development of amyloidosis: Therapeutic efficacy of proton pump inhibitors.
Bertoni A; Carta S; Baldovini C; Penco F; Balza E; Borghini S; Di Duca M; Ognio E; Signori A; Nozza P; Schena F; Castellani P; Pastorino C; Perrone C; Obici L; Martini A; Ceccherini I; Gattorno M; Rubartelli A; Chiesa S
J Allergy Clin Immunol; 2020 Jan; 145(1):368-378.e13. PubMed ID: 31194989
[TBL] [Abstract][Full Text] [Related]
29. Sudden cardiac arrest secondary to cardiac amyloidosis in a young woman with cryopyrin-associated periodic syndrome.
Endo K; Suzuki A; Sato K; Shiga T
BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25883259
[TBL] [Abstract][Full Text] [Related]
30. Anakinra for cryopyrin-associated periodic syndrome.
Koné-Paut I; Galeotti C
Expert Rev Clin Immunol; 2014 Jan; 10(1):7-18. PubMed ID: 24308832
[TBL] [Abstract][Full Text] [Related]
31. [Cryopyrin-associated periodic fever syndrome (CAPS) presenting as early-onset dementia, lacking typical recurrent fever or skin rash: a case report].
Taneda T; Takahashi M; Umeda M; Umeda Y; Oyake M; Nishikomori R; Fujita N
Rinsho Shinkeigaku; 2024 Jun; 64(6):413-416. PubMed ID: 38797686
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry.
Levy R; Gérard L; Kuemmerle-Deschner J; Lachmann HJ; Koné-Paut I; Cantarini L; Woo P; Naselli A; Bader-Meunier B; Insalaco A; Al-Mayouf SM; Ozen S; Hofer M; Frenkel J; Modesto C; Nikishina I; Schwarz T; Martino S; Meini A; Quartier P; Martini A; Ruperto N; Neven B; Gattorno M;
Ann Rheum Dis; 2015 Nov; 74(11):2043-9. PubMed ID: 25038238
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1β monoclonal antibody.
Chakraborty A; Tannenbaum S; Rordorf C; Lowe PJ; Floch D; Gram H; Roy S
Clin Pharmacokinet; 2012 Jun; 51(6):e1-18. PubMed ID: 22550964
[TBL] [Abstract][Full Text] [Related]
34. Two adult siblings with atypical cryopyrin-associated periodic syndrome due to a novel M299V mutation in NLRP3.
Verma D; Eriksson P; Sahdo B; Persson A; Ejdebäck M; Särndahl E; Söderkvist P
Arthritis Rheum; 2010 Jul; 62(7):2138-43. PubMed ID: 20506209
[TBL] [Abstract][Full Text] [Related]
35. NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment.
Kuemmerle-Deschner JB; Lohse P; Koetter I; Dannecker GE; Reess F; Ummenhofer K; Koch S; Tzaribachev N; Bialkowski A; Benseler SM
Arthritis Res Ther; 2011; 13(6):R196. PubMed ID: 22146561
[TBL] [Abstract][Full Text] [Related]
36. Corneal response to canakinumab in cryopyrin associated periodic fever syndrome.
Tsatsos M; Hawkin PN; Hossain P
Br J Ophthalmol; 2013 Aug; 97(8):1081-2. PubMed ID: 23740963
[No Abstract] [Full Text] [Related]
37. Use of canakinumab in the cryopyrin-associated periodic syndrome.
Lachmann HJ; Kone-Paut I; Kuemmerle-Deschner JB; Leslie KS; Hachulla E; Quartier P; Gitton X; Widmer A; Patel N; Hawkins PN;
N Engl J Med; 2009 Jun; 360(23):2416-25. PubMed ID: 19494217
[TBL] [Abstract][Full Text] [Related]
38. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
Hur P; Lomax KG; Ionescu-Ittu R; Manceur AM; Xie J; Cammarota J; Gautam R; Sanghera N; Kim N; Grom AA
Pediatr Rheumatol Online J; 2021 Sep; 19(1):143. PubMed ID: 34521444
[TBL] [Abstract][Full Text] [Related]
39. Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes.
Yadlapati S; Efthimiou P
Mod Rheumatol; 2016; 26(1):3-8. PubMed ID: 26140469
[TBL] [Abstract][Full Text] [Related]
40. A case of cryopyrin-associated periodic syndrome due to somatic mosaic mutation complicated with recurrent circinate erythematous psoriasis.
Ando T; Abe Y; Yamaji K; Nishikomori R; Tamura N
Mod Rheumatol Case Rep; 2024 Jul; 8(2):368-372. PubMed ID: 38036300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
